Who can use Xofluza?
The following information is provided for clinicians and other healthcare professionals. Xofluza is FDA-approved for use in adults and in children ages 12 years and older to: treat acute, uncomplicated influenza* in adults and in children ages 12 years and older.
Does Xofluza treat the common cold?
Xofluza is used to treat flu symptoms caused by the influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Xofluza is also used to prevent flu symptoms in people who have been in contact with someone who has the flu.
How effective is Xofluza?
Xofluza has been shown to be effective at shortening the length of time people have the flu. In clinical studies, flu symptoms were relieved an average of 26 to 29 hours faster in people who took Xofluza than in people who took a placebo. (A placebo is a treatment containing no active drug).
How does Xofluza help prevent the flu?
One-dose XOFLUZA helps protect you and your family members aged 5 years and older from getting the flu. XOFLUZA may help lower your chances of getting the flu by 87% after being exposed to someone who has the flu, compared with placebo. If a family member has been exposed to the flu, you need to act fast because the window for treatment is short.
What is Xofluza used for?
Xofluza is an antiviral medicine for treating and preventing flu in adults and children from 1 year of age. As a treatment, Xofluza is only used for uncomplicated flu (flu without serious effects that may require hospital care). Xofluza contains the active substance baloxavir marboxil. How is Xofluza used? How does Xofluza work?
Can you take Xofluza if you have the flu?
One-dose XOFLUZA can also be given to otherwise healthy patients aged 5 to less than 12 years within 48 hours of experiencing flu symptoms. XOFLUZA treats the flu with one tablet taken one time. Over-the-counter medicines just treat flu symptoms, but prescription one-dose XOFLUZA attacks the flu virus at its source.
Does Xofluza prevent bacterial infections?
XOFLUZA does not treat or prevent illness that is caused by infections other than the influenza virus. XOFLUZA does not prevent bacterial infections that may happen with the flu. It is not known if XOFLUZA is safe and effective for the treatment and prevention of the flu in children less than 5 years of age.
Discuss the significance of leading antiviral medications in Australia in combating viral outbreaks or pandemics, and share opinions on their effectiveness, accessibility, and potential impact on public health.
Dive into the discussion on whether antiviral medications are effective in treating the common cold. Share your insights on cold remedies and explore the potential benefits of using antivirals to alleviate cold symptoms.
Discuss the role of antiviral medications in containing the spread of influenza within communities, including their impact on transmission rates and outbreak control strategies.
Explore the current research projects and innovations aimed at developing new antiviral medications and strategies to overcome antiviral resistance.
Discover the likelihood of antiviral medications triggering gastrointestinal issues in individuals being treated for respiratory infections.
Discuss the concept of combination therapy in combating antiviral resistance in influenza. Share insights on the rationale, efficacy, and challenges associated with using multiple antiviral agents concurrently to overcome resistance and enhance treatment outcomes.
Explore the recommended duration of antiviral medication courses for treating influenza and the importance of completing the prescribed treatment regimen.
Explore the importance of antiviral resistance surveillance in monitoring influenza strains. Share best practices, technology-driven innovations, and global initiatives aimed at enhancing surveillance systems to detect, track, and respond to antiviral resistance outbreaks effectively.
Discuss the important factors that healthcare professionals take into account when selecting an appropriate antiviral medication for treating influenza in patients.
Discuss the link between influenza vaccination coverage and the prevention of antiviral resistance development. Share strategies for promoting vaccination uptake, enhancing immunity, and reducing the reliance on antiviral treatments to mitigate resistance risks.
Examine the interconnectedness between antiviral resistance in animals and its implications for human health. Discuss the potential risks posed by zoonotic transmissions and the importance of addressing antiviral resistance across species.
Examine the impact of antiviral resistance on global health outcomes. Discuss the challenges posed by emerging resistance mechanisms in the context of infectious disease control and public health. Share your perspectives on the broader implications of antiviral resistance for healthcare systems worldwide.
Examine the safety considerations surrounding the use of antiviral medications for influenza in pregnant women and their potential impact on maternal and fetal health.
Explore the effectiveness of leading antiviral medications in Australia in combating prevalent viral infections, and exchange opinions or experiences related to their efficacy.
Explore the current patterns and trends of antiviral resistance in influenza strains globally. Discuss the implications of these patterns on treatment protocols, public health strategies, and the development of new antiviral agents.
Delve into the potential of novel antiviral therapies to transform the approach to treating resistant infections and their impact on patient outcomes.
Discover the role of antiviral medications in combating the flu virus. Share your experiences with flu treatments and find out more about the effectiveness of antivirals in managing flu symptoms.
Delve into the significance of conducting antiviral resistance testing in patients with influenza. Share experiences, best practices, and guidelines for implementing these tests in clinical settings to optimize treatment outcomes and contain resistant strains.
Share the effectiveness of antiviral medications in preventing the flu, including their role in reducing the severity and duration of symptoms.
Discuss the effectiveness of using multiple antiviral drugs to combat viral infections, especially in cases where single-drug treatments are no longer effective. Share insights, experiences, and research findings.
Discuss the effectiveness of antiviral medications in treating influenza, including the benefits, limitations, and important considerations for prescribing.
Discuss the different ways in which antiviral resistance can develop in viruses and the impact it has on treatment options.
